|
STX6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.144400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.493360E-01 |
| Normal-vs-Stage2 |
1.444810E-01 |
| Normal-vs-Stage3 |
1.490610E-01 |
| Normal-vs-Stage4 |
2.787800E-01 |
| Stage1-vs-Stage2 |
5.832000E-01 |
| Stage1-vs-Stage3 |
7.240200E-01 |
| Stage1-vs-Stage4 |
9.634400E-01 |
| Stage2-vs-Stage3 |
8.145800E-01 |
| Stage2-vs-Stage4 |
6.865200E-01 |
| Stage3-vs-Stage4 |
8.453600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.933200E-01 |
| Normal-vs-AfricanAmerican |
6.805300E-04 |
| Normal-vs-Asian |
2.739000E-01 |
| Caucasian-vs-AfricanAmerican |
5.317300E-03 |
| Caucasian-vs-Asian |
7.527600E-01 |
| AfricanAmerican-vs-Asian |
1.550060E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.981600E-02 |
| Normal-vs-Female |
1.251210E-01 |
| Male-vs-Female |
6.494400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.917960E-01 |
| Normal-vs-Age(41-60Yrs) |
1.949640E-01 |
| Normal-vs-Age(61-80Yrs) |
6.844000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.012000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.954200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.920200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.823400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.103800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.071800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.135600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.149600E-01 |
| Classical-VS-Follicular |
7.392200E-01 |
| Classical-VS-Other |
3.036800E-01 |
| Classical-VS-Normal |
5.120400E-02 |
| Tall-VS-Follicular |
2.562600E-01 |
| Tall-VS-Other |
7.304400E-01 |
| Tall-VS-Normal |
9.407800E-01 |
| Follicular-VS-Other |
3.567400E-01 |
| Follicular-VS-Normal |
8.856300E-02 |
| Other-VS-Normal |
6.944000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.856600E-01 |
| Normal-vs-N1 |
9.624200E-01 |
| N0-vs-N1 |
3.672000E-01 |
|
|
